Pen Needles Market Size, Share, Trend Report Analysis 2025

report image

Pen Needles Market to 2025 - Global Analysis and Forecasts By Type (Standard and Safety), Therapy (Insulin, GLP-1, and Growth Hormone), Length (4mm, 5mm, 6mm, 8mm,10mm, and 12mm) and Geography

Publication Month: Aug 2018 | Report Code: TIPHE100000824 | No. of Pages: 150 | Category: Medical Device | Status: Published

The global pen needles market estimated to grow at a CAGR of 4.6% during the forecast period from 2018 to 2025. The market for Pen needles was valued at USD 1,603.8 Mn in 2017 and is estimated to reach US$ 2,280.6 Mn by 2025.

The global pen needles market is segmented on the basis of type, therapy, and length and geography. On the basis of type, the market is segmented into standard pen needles and safety pen needles. On the basis of therapy, the market is segmented into insulin therapy, GLP-1 therapy and growth hormone therapy. Based on length, the global pen needles market is segmented into 4mm, 5mm, 6mm, 8mm, 10mm, and 12mm.

Get more information on this report :

The pen needles market is aimed to describe, define and estimate the forecast for market size of the pen needles till 2025. The report strategically analyzes macro and micro-markets to entail the major factors impacting the growth of the global pen needles market. The market report for pen needles is appropriate to cater the needs and demands of various stakeholders that include manufacturers, distributors and suppliers of pen needles, public and private hospitals, academic medical centers and teaching hospitals, privately practicing physicians and surgeons, medical institutes, research centers and other academic hostilities, pharmacies, ambulatory surgical centers and other distribution channels.

Europe is expected to be the dominant region in the global pen needles market. This dominance is primarily driven by the increasing Prevalence of diabetes is increasing among all ages in the European Region, majorly due to increase in overweight & obesity, unhealthy diet and physical inactivity.

Strategic Insights

Report Coverage - Pen Needles Market
Report CoverageDetails
Market Size Value inUS$ 1,603.8 Million in 2017
Market Size Value byUS$ 2,280.6 Million by 2025
Growth rateCAGR of 4.6% from 2018-2025
Forecast Period2018-2025
Base Year2017
No. of Pages150
Historical data availableYes
Segments coveredType, Therapy, Length, and Geography
Regional scopeNorth America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country scopeUS, Canada, Mexico, UK, Germany, Spain, Italy, France, India, China, Japan, South Korea, Australia, UAE, Saudi Arabia, South Africa, Brazil, Argentina
Report coverageRevenue forecast, company ranking, competitive landscape, growth factors, and trends
Free Sample Copy Available

According to the International Diabetes Federation (IDF) Europe, in 2017, there were 7.476.800 cases of diabetes in Germany. Moreover, approximately 270,000 new cases are recorded in Germany each year. This is expected to drive the market for overall pen needles in this country. On the other hand, Asia Pacific is expected to witness significant growth in the market owing to factors such as increasing focus of market players developing novel products at affordable prices, developing healthcare infrastructure and massive pool of diabetic prevalent population.

The major players operating in the market of pen needles include BD, Novo Nordisk A/S, YPSOMED AG, B. Braun Melsungen AG, Owen Mumford, Ltd., HTL-Strefa S.A., Ultimed, Inc., Terumo Corporation, Allison Medical, Inc., and Artsana S.p.A. among others. The global pen needles market is highly competitive and driven by large number of novel product launches and approvals. For instance, in May 2018, Hindustan Syringes and Medical Devices (HMD), one of the leading manufacturers of disposable syringes introduced “Dispovan” insulin pen needle which is the first made-in-India disposable pen needle that is technologically efficient and affordable than that of the currently available products in the market.

The List of Companies

1. BD
2. Novo Nordisk A/S
4. Braun Melsungen AG
5. Owen Mumford, Ltd.
6. HTL-Strefa S.A.
7. Ultimed, Inc.
8. Terumo Corporation
9. Allison Medical, Inc.
10. Artsana S.p.A.

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the pen needles market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the global pen needles market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market

Have a Question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak to Analyst
  • $3000
  • $4550 $3000
  • $6550 $4000
  • $8550 $5000

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount